Asia Pacific Bioactive Wound Management Market Trends and Analysis by 2027

The Asia Pacific bioactive wound management market is expected to reach US$ 371.34 million by 2027 from US$ 676.54 million in 2019; it is estimated to grow at a CAGR of 7.9% from 2020 to 2027.

The key factors driving the bioactive wound management market aregrowing prevalence of wounds and ulcers and increasing healthcare expenditure in Asia Pacific. However, high cost associated with wound care management is the major factor hindering the market growth in Asia Pacific.

The wound dressing made by using biomaterials is known as bioactive wound care dressings. These wounds dressings use materials that are designed to be in direct contact with the injury and prevent the chances of further infection. These dressing materials are made up of both synthetics as well as natural polymers. The rise in diabetes cases and skin injuries due to burns are expected to fuel the growth of the Asia Pacific bioactive wound management market during the forecast period.

Rising diabetes-associated risks such as diabetic foot ulcers and pressure sores are increasing the demand for bioactive wound care products. Additionally, factors such as antimicrobial resistance, adoption of unhealthy lifestyles, alcohol consumption, and smoking contribute to the rise in the prevalence of non-communicable diseases. As per the International Diabetes Federation (IDF), about 7.3 million people are diagnosed with diabetes in Japan, with a prevalence rate of 7.9%. In China about 116.4 million people are diagnosed with diabetes with a prevalence rate of 10.9%. Moreover, diabetic patients who undergo certain procedures may get surgical wounds. These procedures may cause certain injury in patient in which bioactive wound care products plays an important role in healing such wounds. Bioactive wound management products allow rapid healing of surgical site infection; the rising number of surgical procedures is anticipated to surge the demand for bioactive wound care products in the near future.

The outbreak of the COVID-19 pandemic has affected various Asian countries such as India, South Korea, Australia, Malaysia, and Singapore. The countries have reported maximum deaths and laboratory diagnosed positive patients. The major focus has been shifted to treat COVID-19 affected patients and the production of personal equipment products. On the other hand, Asian countries have a maximum number of burn cases. Countries such as India, Nepal, and Pakistan have ~1 million cases for burn wounds. Therefore, the outbreak of the COVID-19 pandemic is estimated to negatively impact the bioactive wound management market.

Rest of Asia PacificBioactive wound management Market,Revenue and Forecast to 2027 (US$ Mn)

Asia Pacific Bioactive Wound Management Market Segmentation

By Product

• Alginates
• Collagen-based Dressing
• Antimicrobial Dressings
• Bioengineered Skin Substitutes
• Hydrocolloids

By Application

• Burn Wounds
• Surgical Wounds
• Pressure Ulcers
• Diabetic Foot Ulcers
• Venous Leg Ulcers

By End User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

By Country

• China
• Japan
• India
• South Korea
• Australia

Company Profiles

• Smith & Nephew
• Hartman Group
• Integra Life Sciences Corporation
• Coloplast Group
• ConvaTec Group Plc

Asia Pacific Bioactive Wound Management Report Scope